Takara Bio Inc. 4974.T Stock
Takara Bio Inc. Price Chart
Takara Bio Inc. 4974.T Financial and Trading Overview
Takara Bio Inc. stock price | 954 JPY |
Previous Close | 1645 JPY |
Open | 1653 JPY |
Bid | 1663 JPY x 0 |
Ask | 1665 JPY x 0 |
Day's Range | 1648 - 1667 JPY |
52 Week Range | 1609 - 2259 JPY |
Volume | 270K JPY |
Avg. Volume | 189.13K JPY |
Market Cap | 200.37B JPY |
Beta (5Y Monthly) | 0.291187 |
PE Ratio (TTM) | 9.976019 |
EPS (TTM) | 13.05 JPY |
Forward Dividend & Yield | 59 (3.54%) |
Ex-Dividend Date | March 28, 2024 |
1y Target Est | 2300 JPY |
4974.T Valuation Measures
Enterprise Value | 150.21B JPY |
Trailing P/E | 9.976019 |
Forward P/E | 24.568136 |
PEG Ratio (5 yr expected) | 1.01 |
Price/Sales (ttm) | 2.5642066 |
Price/Book (mrq) | 1.7855572 |
Enterprise Value/Revenue | 1.922 |
Enterprise Value/EBITDA | 5.958 |
Trading Information
Takara Bio Inc. Stock Price History
Beta (5Y Monthly) | 0.291187 |
52-Week Change | -7.58% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2259 JPY |
52 Week Low | 1609 JPY |
50-Day Moving Average | 1691.8 JPY |
200-Day Moving Average | 1747.11 JPY |
4974.T Share Statistics
Avg. Volume (3 month) | 189.13K JPY |
Avg. Daily Volume (10-Days) | 191.52K JPY |
Shares Outstanding | 120.42M |
Float | 46.05M |
Short Ratio | N/A |
% Held by Insiders | 60.91% |
% Held by Institutions | 11.21% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 42 |
Trailing Annual Dividend Yield | 2.55% |
5 Year Average Dividend Yield | 75.00% |
Payout Ratio | 0.19790001 |
Last Split Factor | 400:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 20.49% |
Operating Margin (ttm) | 26.20% |
Gross Margin | 57.28% |
EBITDA Margin | 32.26% |
Management Effectiveness
Return on Assets (ttm) | 10.45% |
Return on Equity (ttm) | 15.39% |
Income Statement
Revenue (ttm) | 78.14B JPY |
Revenue Per Share (ttm) | 648.94 JPY |
Quarterly Revenue Growth (yoy) | -18.60% |
Gross Profit (ttm) | N/A |
EBITDA | 25.21B JPY |
Net Income Avi to Common (ttm) | 16.01B JPY |
Diluted EPS (ttm) | 166.8 |
Quarterly Earnings Growth (yoy) | -74.20% |
Balance Sheet
Total Cash (mrq) | 51.85B JPY |
Total Cash Per Share (mrq) | 430.57 JPY |
Total Debt (mrq) | 972M JPY |
Total Debt/Equity (mrq) | 0.86 JPY |
Current Ratio (mrq) | 5.396 |
Book Value Per Share (mrq) | 931.922 |
Cash Flow Statement
Operating Cash Flow (ttm) | 36.9B JPY |
Levered Free Cash Flow (ttm) | 27.4B JPY |
Profile of Takara Bio Inc.
Country | Japan |
State | N/A |
City | Kusatsu |
Address | 7-4-38 Nojihigashi |
ZIP | 525-0058 |
Phone | 81 77 565 6920 |
Website | https://www.takara-bio.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names. It also provides contract services for regenerative medicine products, such as manufacturing of viral vectors and gene-transduced cells, quality and safety testing, and cell banking; and contract services for gene analysis and testing, including sequencing, intestinal flora analysis, comprehensive analysis of cancer-associated genes, and cell line creation through genome editing. In addition, the company is involved in developing platform technology for biologics development in areas, such as gene therapy. The company was incorporated in 2002 and is based in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.
Q&A For Takara Bio Inc. Stock
What is a current 4974.T stock price?
Takara Bio Inc. 4974.T stock price today per share is 954 JPY.
How to purchase Takara Bio Inc. stock?
You can buy 4974.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Takara Bio Inc.?
The stock symbol or ticker of Takara Bio Inc. is 4974.T.
Which industry does the Takara Bio Inc. company belong to?
The Takara Bio Inc. industry is Biotechnology.
How many shares does Takara Bio Inc. have in circulation?
The max supply of Takara Bio Inc. shares is 120.42M.
What is Takara Bio Inc. Price to Earnings Ratio (PE Ratio)?
Takara Bio Inc. PE Ratio is 73.10345000 now.
What was Takara Bio Inc. earnings per share over the trailing 12 months (TTM)?
Takara Bio Inc. EPS is 13.05 JPY over the trailing 12 months.
Which sector does the Takara Bio Inc. company belong to?
The Takara Bio Inc. sector is Healthcare.
Takara Bio Inc. 4974.T included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}